Home › Funds › Sio Capital Management, LLC › QTTB
Sio Capital Management, LLC position in QTTB
Q32 BIO INC · Health Care
Sio Capital Management, LLC reported holding 529,155 shares of QTTB (Q32 BIO INC) in its Q3 2026 13F filing — a position valued at US$4.4M, representing 0.86% of its reported portfolio and ranking #35 among its reported holdings. Sio Capital Management, LLC has disclosed QTTB holdings in 2 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Sio Capital Management, LLC's QTTB position evolved
Sio Capital Management, LLC first disclosed a stake in QTTB in Q4 2024 at 697,413 shares (US$2.4M). The position peaked in Q3 2026 at 529,155 shares, worth US$4.4M. Across 2 filings, Sio Capital Management, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 529,155 shares valued at US$4.4M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 697.41K | $2.40M | New |
| Q3 2026 | 529.15K | $4.38M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About QTTB and 13F data
QTTB (Q32 BIO INC) is a Health Care company. 66 other funds we track also report a position in QTTB — the largest reported positions include ORBIMED ADVISORS LLC (US$52.6M), Boxer Capital Management, LLC (US$40.1M), BVF INC/IL (US$29.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding QTTB
- ORBIMED ADVISORS LLC 4.13M sh · $52.59M · Q2 2026
- Boxer Capital Management, LLC 3.15M sh · $40.12M · Q2 2026
- BVF INC/IL 2.35M sh · $29.94M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 2.72M sh · $22.47M · Q3 2026
- Opaleye Management Inc. 931.00K sh · $11.86M · Q2 2026
- Sanofi 244.08K sh · $2.02M · Q3 2026
- ACORN CAPITAL ADVISORS, LLC 216.17K sh · $1.79M · Q3 2026
- Velan Capital Investment Management LP 120.00K sh · $992.40K · Q3 2026
- Nutshell Asset Management Ltd 98.30K sh · $812.93K · Q3 2026
- B Group, Inc. 65.00K sh · $537.55K · Q3 2026
More on Sio Capital Management, LLC
FAQ
How long has Sio Capital Management, LLC held QTTB?
Sio Capital Management, LLC has disclosed QTTB holdings in 2 of the last 8 reported quarters, going back to Q4 2024.
What is Sio Capital Management, LLC's current position in QTTB?
As of Q3 2026, Sio Capital Management, LLC holds 529.15K shares of QTTB (Q32 BIO INC), valued at $4.38M, representing 0.86% of its reported portfolio and ranking #35.
Has Sio Capital Management, LLC been buying or selling QTTB?
In the latest 13F filing (Q3 2026), Sio Capital Management, LLC newly opened its position in QTTB. The position peaked in Q3 2026 at 529.15K shares.
Which other funds hold QTTB?
Other major institutional holders of QTTB include ORBIMED ADVISORS LLC, Boxer Capital Management, LLC, BVF INC/IL, among 66 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.